← Open Payments lookup

ANISHA NINAN: Open Payments

NPI 1336631886 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$127 in 7 payments from 6 companies in 2025. Trend: 2023 $105 · 2024 $166 · 2025 $127

Food & beverage: $127
CompanyPaymentsAmount
Madrigal Pharmaceuticals2$33
Gilead Sciences, Inc.1$24
Takeda Pharmaceuticals U.S.A., Inc.1$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$18
PFIZER INC.1$17
Alnylam Pharmaceuticals Inc.1$17

Products named: REZDIFFRA, EOHILIA, XIFAXAN, XELJANZ, GIVLAARI.

Industry payments across MD — which companies pay providers there.